Glenn Mattes, TFF Pharmaceuticals CEO

Texas biotech ex­pands R&D and man­u­fac­tur­ing ca­pa­bil­i­ties fol­low­ing Catal­ent part­ner­ship

On­ly months af­ter Texas-based TFF Phar­ma­ceu­ti­cals net­ted a part­ner­ship with Catal­ent, the com­pa­ny is ex­pand­ing its R&D and man­u­fac­tur­ing op­er­a­tions in the cap­i­tal of the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.